<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 7: Treatment Resistance: Identifying Genetic & Metabolic Blockers | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #f9fafb;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 12px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 color: #4c1d95;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 4px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 6px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: #f9fafb;
 padding: 20px 28px;
 border-bottom: 1px solid #e5e7eb;
}

.case-study-header .title {
 color: #722F37;
 font-weight: 700;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 margin-bottom: 8px;
 color: #475569;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.connection-icon {
 font-size: 24px;
}

/* STAT HIGHLIGHT */
.stat-highlight {
 color: #722F37;
 font-weight: 800;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 28: Crisis & Complex Cases</span>
 <h1 class="lesson-title">Treatment Resistance: Identifying Genetic & Metabolic Blockers</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 7 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">Mastery Level</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Excellence</div>
 <div class="title">AccrediPro Standards Institute‚Ñ¢ Certified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#genetic-barriers"><span class="section-num">01</span> The Genetic Wall: COMT & MTHFR</a></li>
 <li><a href="#estrobolome"><span class="section-num">02</span> The Estrobolome: Gut-Hormone Recirculation</a></li>
 <li><a href="#bioavailability"><span class="section-num">03</span> Bioavailability & SHBG Capture</a></li>
 <li><a href="#pivot-strategy"><span class="section-num">04</span> The 12-Week Pivot Strategy</a></li>
 <li><a href="#advanced-labs"><span class="section-num">05</span> Advanced Lab Interpretation</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <span class="connection-icon">üîó</span>
 <div class="connection-text">
 <p>Building on <strong>Module 28, Lesson 6</strong> where we addressed the crisis of POI, we now shift focus to clients who "on paper" should be thriving but remain symptomatic. This lesson bridges the gap between standard protocols and the <strong>bio-individual detective work</strong> required for complex cases.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>As a specialist, you will eventually encounter the "unsolvable" client: the woman who has tried every HRT dose, every supplement, and every dietary shift without relief. These cases aren't failures of the P.H.A.S.E. Framework‚Ñ¢; they are invitations to look deeper into the <strong>metabolic and genetic machinery</strong> that governs how hormones are processed, cleared, and utilized. Today, we master the art of identifying the "blockers" that stall progress.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the impact of COMT, MTHFR, and CYP1B1 polymorphisms on estrogen detoxification.</li>
 <li>Identify the role of beta-glucuronidase and the estrobolome in treatment resistance.</li>
 <li>Evaluate bioavailability issues related to Sex Hormone Binding Globulin (SHBG) and delivery methods.</li>
 <li>Master the "12-Week Pivot" to adjust care plans when clinical progress stalls.</li>
 <li>Interpret advanced functional labs, including Organic Acids (OAT) and comprehensive stool analysis.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <h4 class="title">Case Study: The "HRT-Resistant" Perimenopause</h4>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Linda, 52, former ER Nurse.</p>
 <p><strong>Presenting Symptoms:</strong> Severe insomnia, intractable anxiety, and "internal tremors" despite being on a standard .05mg estradiol patch and 100mg oral progesterone. Linda's previous practitioner kept increasing her dose, but her symptoms only worsened.</p>
 <p><strong>The Blocker:</strong> Genetic testing revealed a <span class="highlight">COMT Val/Val polymorphism</span> (fast COMT) and <span class="highlight">MTHFR 677TT</span>. Her body was clearing dopamine too quickly while struggling to methylate estrogen, leading to a build-up of catechol-estrogens (4-OH) which are neuro-excitatory.</p>
 <p><strong>Outcome:</strong> By adding magnesium glycinate, methylated B-vitamins, and DIM (to shift estrogen pathways), Linda‚Äôs anxiety resolved in 3 weeks without changing her HRT dose.</p>
 </div>
 </div>

 <h2 id="genetic-barriers">The Genetic Wall: COMT, MTHFR & CYP1B1</h2>
 <p>In the <strong>Harmonize (H)</strong> phase of our framework, we assume the body‚Äôs detoxification pathways are functioning at a baseline level. However, genetic Single Nucleotide Polymorphisms (SNPs) can act as significant "speed bumps" in hormone metabolism.</p>
 
 <h3>The COMT Gene (Catechol-O-Methyltransferase)</h3>
 <p>COMT is the enzyme responsible for the second phase of estrogen detoxification (methylation). It is also responsible for breaking down catecholamines (dopamine, norepinephrine, epinephrine). When a client has a "slow" COMT variant, estrogen metabolites and stress hormones linger in the system longer.</p>
 
 <table class="data-table">
 <thead>
 <tr>
 <th>Genotype</th>
 <th>Enzyme Speed</th>
 <th>Clinical Presentation</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Val/Val</strong></td>
 <td>Fast</td>
 <td>Clears dopamine quickly; may struggle with focus/mood; often clears estrogen efficiently.</td>
 </tr>
 <tr>
 <td><strong>Met/Met</strong></td>
 <td>Slow</td>
 <td>High "baseline" anxiety; prone to estrogen dominance; highly sensitive to HRT dose increases.</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">üí° Specialist Insight</span>
 <p>If a client reports feeling "wired and tired" or experiences intense anxiety every time their HRT dose is increased, suspect a <strong>Slow COMT</strong>. These clients need lower doses and heavy support for Phase II detoxification (magnesium, SAMe, and B-vitamins).</p>
 </div>

 <h2 id="estrobolome">The Estrobolome: Gut-Hormone Recirculation</h2>
 <p>Even if the liver successfully processes estrogen, the gut can "undo" all that work. The <strong>estrobolome</strong> is a collection of bacteria in the gut capable of metabolizing and circulating the body‚Äôs estrogen.</p>
 
 <p>The primary culprit in treatment resistance is an enzyme called <span class="highlight">beta-glucuronidase</span>. When this enzyme is elevated (often due to dysbiosis), it uncouples the estrogen that the liver just packaged for excretion. This "free" estrogen is then reabsorbed into the bloodstream.</p>

 <ul>
 <li><strong>The Result:</strong> A client may have high-normal estrogen on a blood test despite being on a low-dose patch, yet they feel "toxic" rather than relieved.</li>
 <li><strong>The Fix:</strong> Calcium D-Glucarate is a specific inhibitor of beta-glucuronidase, allowing the estrogen to stay "packaged" and exit the body.</li>
 </ul>

 <h2 id="bioavailability">Bioavailability & SHBG Capture</h2>
 <p>Sometimes the problem isn't the hormone itself, but its <strong>transportation</strong>. Sex Hormone Binding Globulin (SHBG) is a protein produced by the liver that acts as a "carrier" for estrogen and testosterone.</p>
 
 <p>If SHBG is too high, it binds up the hormones, leaving very little "free" (active) hormone for the tissues to use. A woman might have "perfect" total estrogen levels on a lab report, but if her SHBG is <span class="stat-highlight">>120 nmol/L</span>, she will remain symptomatic for vaginal dryness, brain fog, and low libido.</p>

 <div class="coach-tip">
 <span class="tip-label">üí° Specialist Insight</span>
 <p>Common causes of high SHBG in midlife include high-dose oral estrogen (first-pass effect), hyperthyroidism, and extremely low-carb diets. If you see high SHBG, pivot the strategy to <strong>transdermal</strong> delivery and ensure adequate carbohydrate intake for thyroid health.</p>
 </div>

 <h2 id="pivot-strategy">The 12-Week Pivot Strategy</h2>
 <p>In a professional practice, time is your most valuable diagnostic tool. We use the <strong>12-Week Rule</strong> to prevent client burnout and ensure we aren't "chasing symptoms."</p>

 <div class="case-study" style="border-left-color: #B8860B;">
 <div class="case-study-header">
 <h4 class="title" style="color: #722F37;">Clinical Protocol: The Pivot</h4>
 </div>
 <div class="case-study-content">
 <p><strong>Weeks 1-4:</strong> Implementation of basic P.H.A.S.E. protocols (Nutrition, basic HRT support, movement).</p>
 <p><strong>Weeks 5-8:</strong> Fine-tuning and dose adjustment. Expected improvement: 40-60% reduction in primary symptoms.</p>
 <p><strong>Weeks 9-12:</strong> The Plateau. If symptoms are stagnant or worsening, you <strong>MUST PIVOT</strong>.</p>
 <p><strong>The Pivot Action:</strong> Stop adjusting doses. Order Advanced Labs (Dutch Test, GI-MAP, or Genetic SNPs). Shift from "Hormone Balancing" to "Metabolic Clearing."</p>
 </div>
 </div>

 <h2 id="advanced-labs">Advanced Lab Interpretation</h2>
 <p>Standard FSH and Estradiol tests are snapshots. To solve complex cases, we need the "full movie" provided by functional testing.</p>

 <h3>1. Organic Acids Test (OAT)</h3>
 <p>This urine test looks at metabolic byproducts. It can identify <strong>Mitochondrial dysfunction</strong> (why she‚Äôs so fatigued despite normal thyroid) and <strong>Neurotransmitter metabolites</strong> (why she‚Äôs depressed despite HRT).</p>

 <h3>2. The DUTCH Test (Dried Urine Test for Comprehensive Hormones)</h3>
 <p>Crucial for complex cases because it shows <strong>metabolites</strong>. It answers: Is she pushing estrogen down the protective 2-OH pathway, or the potentially carcinogenic/anxiety-inducing 4-OH pathway? This is essential for clients with a family history of breast cancer or those with the CYP1B1 SNP.</p>

 <div class="coach-tip">
 <span class="tip-label">üí° Specialist Insight</span>
 <p>Practitioners who master these advanced labs can easily command <strong>$997+ for a 90-day "Complex Recovery" package</strong>. You are no longer just a "health coach"; you are a metabolic detective solving problems that doctors often miss.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why might a client with a "Slow COMT" genotype react poorly to an increase in HRT dosage?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">A Slow COMT enzyme clears both estrogen and catecholamines (like dopamine) slowly. Increasing HRT can lead to an accumulation of estrogen metabolites and neurotransmitters, resulting in increased anxiety, irritability, and "jitters" rather than symptom relief.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the role of beta-glucuronidase in the estrobolome?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Beta-glucuronidase is an enzyme that "de-conjugates" (unpackages) estrogen in the gut. This allows estrogen that was meant for excretion to be reabsorbed into the bloodstream, leading to recirculating estrogen levels and persistent symptoms of estrogen dominance.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. If a client has high SHBG (>130 nmol/L), what is the likely impact on her "Free Estradiol" levels?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">High SHBG will "bind up" more of the available estradiol, leaving less "Free" hormone available to bind to cellular receptors. This means the client will likely remain symptomatic for menopause even if her "Total" estradiol levels look normal on a lab test.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. When should a practitioner initiate the "Pivot Strategy"?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The pivot should occur around the 12-week mark if clinical progress has stalled or symptoms are worsening despite standard P.H.A.S.E. Framework‚Ñ¢ interventions. This involves shifting from standard protocols to advanced functional testing.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Genetics Matter:</strong> SNPs like COMT and MTHFR determine the speed and safety of hormone detoxification; they are the "hidden" reasons for HRT sensitivity.</li>
 <li><strong>The Gut is the Drain:</strong> If the estrobolome is dysfunctional (high beta-glucuronidase), hormones will recirculate, causing treatment resistance.</li>
 <li><strong>SHBG is the Gatekeeper:</strong> Always check SHBG to ensure the hormones you are introducing are actually reaching the tissues.</li>
 <li><strong>Don't Chase Symptoms:</strong> Use the 12-Week Pivot to stop guessing and start testing when a client isn't responding to standard care.</li>
 <li><strong>Expertise Equals Value:</strong> Identifying these blockers is what separates a Master Specialist from a general wellness coach.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Ervin, S. M., et al. (2019). "Gut Microbial Œ≤-Glucuronidases: A Target for Personalized Medicine." <em>Journal of Biological Chemistry.</em></li>
 <li>Yager, J. D. (2015). "Catechol-O-Methyltransferase: Role in Breast Cancer and Target for Therapy." <em>Molecular and Cellular Endocrinology.</em></li>
 <li>Kwa, M., et al. (2016). "The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer." <em>Journal of the National Cancer Institute.</em></li>
 <li>Raftogianis, R., et al. (2000). "Estrogen Metabolism by Conjugation." <em>Journal of the National Cancer Institute Monographs.</em></li>
 <li>Simpkins, J. W., et al. (2012). "The Role of SHBG in the Delivery of Sex Steroids to Tissues." <em>Steroids Journal.</em></li>
 <li>Lord, R. S., & Bralley, J. A. (2008). <em>Laboratory Evaluations for Integrative and Functional Medicine.</em> Metametrix Institute.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 this.textContent = answer.style.display === 'block' ? 'Hide Answer' : 'Reveal Answer';
 }
 });
 });
</script>

</body>
</html>